STOCK TITAN

Zomedica (ZOM) Stock News, Sep-Dec 2023

ZOM NYSE

Zomedica Corp. develops and commercializes animal-health diagnostic and therapeutic device products for equine and companion-animal care. Company news commonly covers expansion of the TRUFORMA point-of-care diagnostic menu, including equine endocrine and reproductive assays, and updates for therapeutic brands such as PulseVet, Assisi, Calmer Canine, EquiLoop, and VETIGEL.

Recurring updates also address product launches, veterinary monitoring technology such as the VETGuardian Zero Touch monitor, distribution arrangements for international markets, investor webinars, financial results, and the development-services segment tied to engineering, contract manufacturing, and intellectual-property licensing.

-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.55%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.93%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.54%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.86%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.94%
Tags
conferences
-
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.22%
Tags
none

FAQ

What is the current stock price of Zomedica (ZOM)?

Zomedica (ZOM) last closed at $0.0973.